Free Trial
OTCMKTS:USAQ

QHSLab Q4 2023 Earnings Results & Report

QHSLab logo
$0.27 -0.05 (-16.20%)
As of 10:00 AM Eastern

QHSLab reported Q4 2023 earnings on March 27, 2024. The company reported EPS of -$0.01, while revenue was $320 thousand.

Earnings Announcement Details

Quarter
Q4 2023
Report Date

QHSLab EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

QHSLab Revenue Results

Actual Revenue
$320 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

QHSLab's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

QHSLab Q4 2023 Earnings FAQ

QHSLab (OTCMKTS:USAQ) reported earnings of -$0.01 per share for Q4 2023. The report was announced on Wednesday, March 27, 2024.

QHSLab reported revenue of $320 thousand for Q4 2023.

QHSLab's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for QHSLab on the company's earnings history page.

QHSLab Earnings Headlines

QHSLab (OTCMKTS:USAQ) Stock Jumps 26.7% - Time to Buy?
My prediction for December 8th
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
QHSLab Inc.
See More QHSLab Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like QHSLab? Sign up for Earnings360's daily newsletter to receive timely earnings updates on QHSLab and other key companies, straight to your email.

About QHSLab

QHSLab (OTCMKTS:USAQ) is a healthcare technology and diagnostic services company focused on supporting the identification and management of chronic health conditions. The company combines laboratory testing with clinical decision-support tools intended to help healthcare providers make more informed treatment decisions.

Its offerings include diagnostic testing services and related digital or analytical solutions designed for use by medical professionals. These tools are intended to provide clinical information that can assist with patient evaluation, monitoring and ongoing care.

QHSLab serves the healthcare market through provider-focused products and services. Publicly available information about the company’s operating history, geographic reach and leadership is limited.

View QHSLab Profile